Proscia
Company

Last deal

$9M

Amount

Series C

Stage

13.03.2024

Date

8

all rounds

$89.5M

Total amount

General

About Company
Proscia accelerates pathology's digital transformation, revolutionizing disease understanding.

Industry

Sector :

Subsector :

Keywords :

founded date

01.07.2014

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company's Concentriq digital pathology platform and powerful AI applications unlock hidden data not visible to the human eye, enabling physicians to improve patient outcomes and accelerate the development of life-saving advances. Leading diagnostic laboratories and 10 of the top 20 pharmaceutical companies rely on Proscia's software each day.
Contacts